The Federal Circuit Court of Appeals issued a significant ruling on August 10, 2026, regarding the patent dispute between Dental Monitoring SAS and Align Technology, Inc. The court vacated a previous decision that deemed claims of Dental Monitoring's patent unpatentable. This ruling could have major implications for both companies and the dental technology industry.
The case (docket number 25-1752) involves Dental Monitoring's U.S. Patent 10,755,409, which relates to a method for acquiring and analyzing dental images using deep learning technology. The court's decision affects how patents are evaluated for obviousness and could influence future patent applications in the tech and healthcare sectors.
Background
Dental Monitoring SAS is a company that specializes in dental technology, particularly in monitoring patients' dental health through advanced imaging techniques. The company holds the '409 patent, which outlines a method for capturing and analyzing images of a patient's dental arch. The method involves several steps, including image acquisition, analysis using a deep learning device, and comparing image attributes to predetermined standards.
Align Technology, Inc. is a competitor in the dental technology market, known for its innovative products, including clear aligners. In 2023, Align filed a petition for inter partes review (IPR) at the United States Patent and Trademark Office, challenging the patentability of claims 1-15 of Dental Monitoring's patent. The dispute centered on whether the claims were obvious in light of prior art, specifically a combination of three references: a WIPO patent application, a U.S. patent application, and a published paper on convolutional neural networks.
The Patent Trial and Appeal Board (PTAB) initially ruled in favor of Align, determining that the claims were unpatentable as obvious. The Board's decision was based on its interpretation of the effective filing date of the '409 patent and whether certain prior art could be considered valid.
The Ruling
The Federal Circuit reviewed the PTAB's decision and focused on the legal question of whether Align's referenced patent, known as Carrier, qualified as prior art under the relevant statutes. The court found that the Board had erred in its interpretation of the law regarding the effective filing date of the Carrier patent.
The court ruled, "To establish Carrier as prior art to the '409 patent, Align must show that Carrier's provisional application provides written description support for at least one claim of Carrier."
This statement highlights the court's emphasis on the necessity for a patent to meet specific statutory requirements to be considered valid prior art. The Federal Circuit vacated the Board's decision and remanded the case for further consideration, indicating that the Board must reassess whether the Carrier provisional application meets the necessary criteria.
Impact
The ruling has significant implications for both Dental Monitoring and Align Technology. For Dental Monitoring, the court's decision provides a renewed opportunity to defend its patent claims and potentially secure its market position against competitors. For Align Technology, the ruling means that it must now provide additional evidence to support its claims regarding the prior art status of the Carrier patent.
This case also sets a precedent regarding the interpretation of patent law under the America Invents Act (AIA). The Federal Circuit's ruling clarifies that the requirements for establishing prior art are not merely procedural but require substantive support under the law. This could influence how future patent disputes are resolved, particularly in the tech industry where rapid innovation often leads to complex patent challenges.
What's Next
The case will return to the PTAB for further proceedings, where the Board will need to evaluate whether Align can substantiate its claims regarding the Carrier patent. Depending on the outcome, there may be further appeals or related cases that arise from this ruling.